Ignite Creation Date:
2024-05-05 @ 9:06 PM
Last Modification Date:
2024-10-26 @ 9:59 AM
Study NCT ID:
NCT00819897
Status:
TERMINATED
Last Update Posted:
2016-05-12
First Post:
2009-01-08
Brief Title:
Longitudinal Study in Clinically Isolated Syndrome CIS Patients Treated With Interferon Beta
Sponsor:
Centre Hospitalier Universitaire de Nice
Organization:
Centre Hospitalier Universitaire de Nice
Study Overview
Official Title:
Longitudinal Study in Clinical Isolated Syndrome Patients Treated With Interferon Beta Correlation With Cognitive Disorders and Quality of Life
Status:
TERMINATED
Status Verified Date:
2016-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
QUALICIS
Brief Summary:
The aim of this study is to evaluate the role of cognitive disorders and quality of life in patients with CIS considered as high risk to develop an MS treated with interferon Beta This prospective observational study will include 120 patients all treated and evaluated annually with neurological extensive examination ophthalmologic screening OCT OF VEP VF auto questionnaire about fatigue musicol ELIF quality of life SEP-59 and conventional MRI
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None